Vice President, Commercialization

Rebekah oversees VentureWell’s participation in the NIH Rapid Acceleration of Diagnostics (RADx) initiative and provides support and expertise across VentureWell’s biomedical engineering and medical technology-focused programs. Prior to VentureWell, she managed a portfolio of investments in discovery science, technology, and innovation ecosystem development, focused on early-stage innovation and innovators as a Program Officer at the Bill & Melinda Gates Foundation. Rebekah holds a Ph.D. in biomedical engineering from the University of Virginia and a B.S. in biomedical engineering from Georgia Tech.

By continuing to use the site, you agree to the use of cookies. Read More